Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-17

Clinical Trial Update: Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing risperidone for repetitive behaviors in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Autism | Phase 2 | Status: COMPLETED